MedTrace Logo

ProVIDE II Bridging Study

NCT06236802 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-06-10

No results posted yet for this study

Summary

The purpose of the ProVIDE II Bridging Study is to evaluate the performance of the Generation II delivery system when deploying the ProVee expander in subjects with symptomatic urinary obstruction secondary to BPH.

Conditions

  • BPH With Symptomatic Lower Urinary Tract Symptoms

Interventions

DEVICE

ProVee device

ProVee Expander is placed in prostatic urethra to relieve obstruction due to BPH.

Sponsors & Collaborators

  • ProVerum Medical

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-06
Primary Completion
2024-09-06
Completion
2029-06-01
FDA Device
Yes

Countries

  • United States
  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06236802 on ClinicalTrials.gov